Skip to Content
Merck
All Photos(1)

Key Documents

R211-500

Sigma-Aldrich

Rat Endothelial Cell Growth Medium (500 ml)

Synonym(s):

Primary Cell Culture Media

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352207
NACRES:
NA.71

form

liquid

Quality Level

shelf life

6 mo.

manufacturer/tradename

Cell Applications, Inc

shipped in

wet ice

storage temp.

2-8°C

General description

All-in-one ready-to-use media

Application

Rat Endothelial Cell Growth Medium (500 ml) has been used to culture primary rat endothelial cells and rat aortic endothelial cells.

Quality

Each lot was tested for the ability to support plating, spreading and proliferation

Preparation Note

contained in protocol

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Gang Xi et al.
Journal of diabetes research, 2019, 6456032-6456032 (2019-05-03)
Hyperglycemia results in inhibition of cleavage of integrin-associated protein (IAP) thereby allowing it to bind to SHPS-1 which results in pathophysiologic changes in endothelial function. This study determined if an anti-rat IAP antibody directed against the SHPS-1 binding site which
Qin Huang et al.
Acta diabetologica, 49(3), 205-214 (2011-05-04)
Endothelial cell (EC) survival is critical in the maintenance of endothelial function as well as in the regulation of angiogenesis and vessel integrity since endothelial dysfunction is the initial lesion of atherosclerosis. The goal of this study was to examine
Molly Wasserman Meyers et al.
Physiological reports, 5(4) (2017-03-01)
Surgical and endovascular therapies for severe atherosclerosis often fail due to the development of neointimal hyperplasia and arterial restenosis. Our objective was to synthesize, characterize, and evaluate the targeting specificity and biocompatibility of a novel systemically injected nanoparticle. We hypothesize

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service